Half-year report · HY
6062.TEDINET S100XJIE
Period2025-07-01 → 2025-12-31
Filed2026-02-05
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.3bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥46.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.1bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥53.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥52.4bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥53.0bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.8bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥31.7bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥21.4bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.7bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.0bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.6bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.6bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.7bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.41 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.89 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.93 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.34 | 2025-07-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.77 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.88 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 40.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-07-01 → 2025-12-31 | ¥1.3bn |
| Otherother segments | revenue external | 2025-07-01 → 2025-12-31 | ¥990m |
| Otherother segments | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥324m |
| Otherother segments | segment profit | 2025-07-01 → 2025-12-31 | ¥23m |
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥324m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥324m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥617m |
| Nursing Carereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥21.3bn |
| Nursing Carereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥21.3bn |
| Nursing Carereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| —segment total | revenue | 2025-07-01 → 2025-12-31 | ¥22.7bn |
| —segment total | revenue external | 2025-07-01 → 2025-12-31 | ¥22.3bn |
| —segment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥324m |
| —segment total | segment profit | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| Otherother segments | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Otherother segments | revenue external | 2024-07-01 → 2024-12-31 | ¥1.1bn |
| Otherother segments | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥302m |
| Otherother segments | segment profit | 2024-07-01 → 2024-12-31 | −¥1m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥302m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥302m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥623m |
| Nursing Carereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥18.9bn |
| Nursing Carereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥18.9bn |
| Nursing Carereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
| —segment total | revenue | 2024-07-01 → 2024-12-31 | ¥20.4bn |
| —segment total | revenue external | 2024-07-01 → 2024-12-31 | ¥20.1bn |
| —segment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥302m |
| —segment total | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 491
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)BAHNHOFSTRASSE 45,8001 ZURICH, SWITZERLAND（東京都新宿区新宿６丁目27－30） | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東急不動産株式会社 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都渋谷区道玄坂１丁目21－１ | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)STATE STREET BANK AND TRUST COMPANY 505044（常任代理人 株式会社みずほ銀行） | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)THE BANK OF NEWYORK 134088（常任代理人 株式会社みずほ銀行） | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)BOULEVARD ANSPACH 1, 1000 BRUSSELS,BELGIUM（東京都港区港南２丁目15－１） | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。 | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社チャーム・ケア・コーポレーション | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)大阪市北区中之島三丁目６番32号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes regarding pledged assets (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |